Associate Vice President - Assistant General Counsel, Business Development Transactions

Chester, Maryland, United States

Auto‑apply with AI Apply

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, Legal ServicesIndustries

Requirements

Candidates must possess a J.D. from an ABA-accredited law school and be admitted to the bar in at least one of the fifty states, as well as be eligible for admission to the bar in Indiana under Indiana Admissions Rules. They must also have a minimum of 10 years of legal experience related to drafting, reviewing, and negotiating corporate transactions, specifically in pharmaceutical intellectual property licensing, mergers and acquisitions, and other related transitions, collaborations, technology platforms, or innovative transactions, partnerships, and equity or venture capital-related financings, either through law firm experience or in-house experience at a pharmaceutical or biotechnology company.

Responsibilities

The Associate Vice President will lead and manage a broad range of corporate transactions and lead cross-functional project teams, collaborating with senior business stakeholders to ensure high-level service and counsel. They will advise on complex business transactions, design transaction structures, lead contract negotiation teams, consolidate input from across the Lilly enterprise, and partner with Lilly’s senior management to enable efficient execution. The role involves drafting, reviewing, and negotiating complex agreements related to pharmaceutical intellectual property and other assets, as well as collaboration agreements, and driving large negotiation teams across various functions including business development, finance, and research & development.

Skills

Corporate Transactions

Mergers and Acquisitions

Research and Technology Collaborations

Partnership Negotiation

Legal Drafting

Legal Review

Negotiation

Leadership

Cross-functional Collaboration

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free